BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Panacea Pharmaceuticals

Panacea Pharmaceuticals, Inc. focuses on developing and utilizing protein-based technologies to detect and identify changes associated with and involved in diseases of the central nervous system such as Alzheimer's disease, brain tumors, transmissible spongiform encephalopathies, and Lewy Body diseases such as Parkinson's disease. Changes in disease-relevant proteins by altered expression, post-translational modification, and functional variation are utilized to develop diagnostic tests and therapeutic agents.


Contact Details:
9700 Great Seneca Highway
Rockville
MD
20850
United States of America
Tel:240 453 6295
Fax:240 465 0450
Email:info@PanaceaPharma.com
WWW:

www.panaceapharma.com/




Loading...

Recent Publications by Panacea Pharmaceuticals:

Neuroprotective activity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (PAN-811), a cancer therapeutic agent.
3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) is a...
9th September, 2006
Neurodegenerative Diseases, Panacea Pharmaceuticals, Inc., Gaithersburg, CNS Drug Rev. 2006 Spring;12(1):77-90.
DOI Direct Link
A multifunctional cytoprotective agent that reduces neurodegeneration after ischemia.
Cellular and molecular pathways underlying ischemic neurotoxicity are...
22nd March, 2006
Panacea Pharmaceuticals, Inc., Gaithersburg, MD 20877, USA. Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1581-6. Epub 2006 Jan 19.
DOI Direct Link
Risk Factors Versus Alzheimer's Disease or Symptoms Associated with Alzheimer's Disease.
Cellular and molecular pathways underlying ischemic neurotoxicity are...
6th September, 2002
Panacea Pharmaceuticals Inc., 9700 Great Seneca Highway, Rockville, MD J Alzheimers Dis. 2000 Jun;2(2):117.

Panacea Pharmaceuticals Patents:

US Patent No.Title
6780971 Compositions for inhibiting the aggregation pathway of .alpha.-synuclein
6299875 Methods to block IGE binding to cell surface receptors of mast cells
6238925 Method for determining likelihood of developing clinical tolerance

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 403 times since April 2007, the link to the organisation's website has been followed 64 times

Recent Search Terms used to find this page: panacea pharmaceuticals patent | panacea pharmaceuticals 2008 | panacea pharma | Panacea pharma | t | panacea pharmaceuticals 2008 | t | panacea pharmaceuticals 2008 | PANACEA PHARM GAITHERSBURG | panacea pharma | .

Search for more companies in Rockville

Search for more companies in MD



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Panacea Pharmaceuticals
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.